News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

eyeonics, Inc. (TM) Sponsors Seminar On Accommodative Function Of Crystalens(R) At ASCRS

3/16/2006 11:22:47 AM

ALISO VIEJO, Calif., March 16 /PRNewswire/ -- eyeonics, inc., the developer and manufacturer of the crystalens, the first and only FDA approved accommodating intraocular lens, today announced that it is sponsoring a seminar on the accommodative function of the crystalens at the American Society of Cataract and Refractive Surgery's 2006 Symposium. The seminar, Breakfast With Champions: Understanding Accommodative Mechanism of Action of the crystalens, will be held on Saturday, March 18 from 7:00 to 9:00 a.m. in room 132 of the Moscone Convention Center in San Francisco.

Accommodation is the automatic function by which the human eye brings objects at different distances into focus. Much like the accommodation of the eye's natural crystalline lens, eyeonics' patented crystalens technology not only moves back and forth with the muscles of the eye, but the optic itself flexes or arches, which allows patients to focus through a continuous range of near, far and intermediate vision. The crystalens has now been implanted in more than 40,000 eyes, worldwide.

In the seminar, leading ophthalmic surgeons from across the country will survey the clinical evidence of the crystalen's accommodative function and address perceptions of accommodation in clinical practice, industry and the marketplace. The seminar is open to all ASCRS 2006 attendees.

"eyeonics is delighted that such a distinguished panel will share its clinical experience with crystalens at ASCRS," said J. Andy Corley, Chairman and CEO of eyeonics. "It is worth noting that two members of our panel, as well as several other clinicians, are also presenting clinical data on the crystalens' accommodative function during the Symposium's General Session. The bountiful attention being given to crystalens' accommodative function at ASCRS is significant and exciting validation of eyeonics' proprietary technology and the unique value it offers patients with presbyopia. We encourage ASCRS participants to attend these events."

About the Seminar

Steven Dell, MD, will begin the seminar by underscoring the heightened attention accommodation is receiving by lens and surgical device manufacturers. Dr. James C. Loden will define accommodation by reviewing published clinical evidence to distinguish it from so-called pseueudoaccommodation, and to distinguish crystalens from multi-focal lenses.

Additional presentations by Kevin L. Waltz, OD, MD, Sheri Rowen, MD, and Michael Colvard, MD, will demonstrate the mechanism of action and accommodative arching, how the accommodative function can be measured and how crystalens provides a predictable, positive outcome for patients with presbyopia.

General Session Presentations -- Potential Additional Mechanisms of Accommodation with the crystalens IOL, presented by Dr. Dell on March 19 at 8:17 a.m. -- Accommodative Arching of the Natural Lens and the crystalens IOL, presented by Dr. Waltz on March 19 at 8:07 a.m. -- Alternative Options to Provide Full-Spectrum Vision, presented by Richard Lindstrom, MD, on March 19 at 3:02 p.m. About crystalens

The crystalens is the result of more than 14 years of research and development by J. Stuart Cumming, M.D., F.A.C.S., and was approved by the FDA in November 2003. More than 40,000 lenses have been implanted worldwide to date. During clinical trials, all of the patients who received the crystalens greatly reduced their need for corrective lenses or eyeglasses. The patented crystalens technology is designed to allow the lens to move in the eye in a manner similar to the natural lens. By using the eye's muscle to move the lens back and forwards naturally, patients can focus through a continuous range of vision including near, far and everywhere in between. All other intraocular lenses are designed to remain fixed in the eye. For more information about the crystalens go to

About eyeonics, inc.(TM)

eyeonics is a privately held medical device company headquartered in Aliso Viejo, California, founded in 1998. eyeonics is committed to developing a new class of visual enhancement systems that will enable patients to see up close, far away and all distances in between. For more information about eyeonics, inc. and the crystalens go to or

Contact: EVC Group, Inc. Doug Sherk or Jennifer Buegelmans 415-896-6820 Media: Steve DiMattia 646-277-8706

eyeonics, inc.

CONTACT: Doug Sherk, or Jennifer Buegelmans, +1-415-896-6820, or media,Steve DiMattia, +1-646-277-8706, all of EVC Group, Inc. for eyeonics, inc.

Read at

comments powered by Disqus